Trial Profile
Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Acronyms PRADOTIM
- 31 Jul 2020 Status changed from recruiting to completed.
- 24 Oct 2018 Planned End Date changed from 1 Jul 2016 to 1 Jul 2019.
- 24 Oct 2018 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2019.